Concord Medical Services Holdings (CCM) EBITDA (2009 - 2025)

Concord Medical Services Holdings (CCM) has reported EBITDA for 17 consecutive years, with -$312.6 billion the latest figure, recorded in Q2 2025.

• EBITDA for Q2 2025 came in at -$312.6 billion, down 6.22% year-over-year; the trailing twelve-month figure through Jun 2025 was -$312.6 billion (down 6.22% YoY), and the FY2025 annual result was -$54.0 million, down 23.12% from the prior year.
• EBITDA was -$312.6 billion for Q2 2025 at Concord Medical Services Holdings, up from -$317.5 billion in the prior quarter.
• Over five years, EBITDA peaked at -$25.6 million in Q2 2021 and troughed at -$317.5 billion in Q4 2024.
• Average EBITDA over 5 years is -$159.3 billion, with a median of -$214.3 billion recorded in 2021.
• Year-over-year, EBITDA jumped 99.88% in 2022 and sank 113603.43% in 2024.
• Over 5 years, EBITDA stood at -$214.3 billion in 2021, then soared by 99.88% to -$262.1 million in 2022, then slumped by 112350.41% to -$294.7 billion in 2023, then fell by 7.72% to -$317.5 billion in 2024, then advanced by 1.53% to -$312.6 billion in 2025.
• Per Business Quant data, the three most recent EBITDA figures were -$312.6 billion in Q2 2025, -$317.5 billion in Q4 2024, and -$294.3 billion in Q2 2024.